Press release
Cancer/Tumor Profiling Market Key Manufacturers, Development Trends And Competitive Analysis 2019
With more than 14 million new cases and over 8.2 million deaths (U.S. National Cancer Institute) directly related to complications led by the disease, cancer has become one of the leading socioeconomic burdens and most prevalent cause of deaths across the globe. The WHO states that the disease will lead to the death of over 11.5 million people by 2030 across the globe. The alarmingly rising prevalence of the disease has driven vast research and development activities in the field of cancer diagnosis and treatment in the past few years.Browse Premium Industry Research Report with Analysis: https://www.transparencymarketresearch.com/cancer-tumor-profiling.html
The field of cancer diagnosis has significantly evolved and a number of ways, including medical imaging and screening tests, are being increasingly used for diagnosing the onset or the growth of the tumor tissue. In present times, tumor profiling is also increasingly undertaken to allow the physician a better understanding of the patient’s genomic alterations and cancer profile to decide on a suitable course of therapy. Cancer/tumor profiling is also undertaken to rule out a therapy that is unlikely to provide successful outcomes, thus reducing the time, energy, and money spent in the trial and error approach.
The global market for cancer/tumor profiling is expected to witness expansion at a significant pace in the next few years, chiefly owing to the rising funds being directed towards activities aimed at improving the overall course of diagnosis and treatment of the disease and vast technological advancements recently observed in the field of tumor profiling. The market is also driven by the rising adoption of point of care diagnostics and the resultant rise in demand for personalized medicines.
Request for Sample Copy of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2395
The continuously rising socioeconomic burden of cancer and the pressure on the healthcare industry to present effective methods of tackling and managing the condition are also driving the market for cancer/tumor profiling. However, the added expenditure that profiling procedures require could hinder their adoption to a certain extent, limiting the scope of these procedures to high-income regions. Nevertheless, rising government intervention and pouring funds from public and private institutions towards the diagnosis and treatment of cancer are expected to allow the market achieve promising growth avenues.
Some of the leading vendors operating in the global market for cancer/tumor profiling are Caris Life Sciences, Genomic Health, Inc., Life Technologies Corporation, Boreal Genomics, Inc., Ribomed Biotechnologies, Oxford Gene Technology Ltd., Illumina, Inc., Oncopath Laboratory, Precision Therapeutics, Inc., Neogenomics Laboratories, Precision Therapeutics, Inc., and Nanostring Technologies.
Request Table of Content of Report: https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2395
About Us
Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.
Each TMR syndicated research report covers a different sector – such as pharmaceuticals, chemicals, energy, food & beverages, semiconductors, med-devices, consumer goods and technology. These reports provide in-depth analysis and deep segmentation to possible micro levels. With wider scope and stratified research methodology, TMR’s syndicated reports strive to provide clients to serve their overall research requirement.
Contact US:
Transparency Market Research,
90 State Street,
Suite 700,
Albany NY – 12207
United States
Tel: +1-518-618-1030
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer/Tumor Profiling Market Key Manufacturers, Development Trends And Competitive Analysis 2019 here
News-ID: 976270 • Views: …
More Releases from Transparency Market Research
Global RTD Coffee Market Outlook 2031: Growth Dynamics, Consumer Trends, Regiona …
The global ready-to-drink (RTD) coffee market continues to demonstrate robust expansion driven by evolving consumer lifestyles, increasing preference for convenience beverages, and the rising cultural acceptance of coffee across both developed and emerging economies. Valued at US$ 12.6 Bn in 2022, the market is projected to grow at a compelling CAGR of 8.4% from 2023 to 2031, ultimately reaching US$ 26.0 Bn by 2031. This rapid rise highlights a fundamental…
Rigid Laparoscopes Market Outlook 2035: Global Expansion Driven by Minimally Inv …
The global rigid laparoscopes market continues to evolve rapidly as healthcare systems worldwide adopt minimally invasive surgical (MIS) techniques as a standard of care. Valued at US$ 1.5 billion in 2024, the market is projected to reach US$ 2.3 billion by 2035, advancing at a CAGR of 4.2% from 2025 to 2035. Growing clinical need for precision-driven procedures, advancements in imaging technologies, and the rising global prevalence of gastrointestinal, gynecological,…
Cassava Bags Market Outlook 2035: Global Growth Analysis, Market Size Evolution …
The global cassava bags market has entered a transformative growth phase as governments, retailers, and consumers increasingly prioritize sustainable packaging solutions. Valued at US$ 72.1 Mn in 2024, the market is forecast to reach US$ 145.0 Mn by 2035, reflecting a compound annual growth rate (CAGR) of 6.6% between 2025 and 2035. Cassava-based bags-manufactured from thermoplastic starch, biodegradable blends, or water-soluble compositions-are rapidly becoming mainstream alternatives to conventional plastic bags…
Global RFID Chips Market to Reach USD 23.2 Bn by 2031 as Industries Accelerate A …
The global RFID chips market was valued at US$ 8.1 Bn in 2022 and is projected to advance at a strong CAGR of 12.3% from 2023 to 2031, reaching US$ 23.2 Bn by the end of 2031. The rapid adoption of automation, expansion of retail and e-commerce, and the integration of RFID with next-generation IoT technologies continue to shape the market's growth trajectory.
Access an overview of significant conclusions from our…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
